Sabirin, Samira D.
HRN: 13-26-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/12/2025
CEFTRIAXONE 1G (VIAL)
02/12/2025
02/15/2025
IV DRIP
1.4g
OD
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes